The LSM advisory board is designed to bring together industry leaders, scientific and medical experts, and corporate executives who can provide guidance and feedback on both curricular and co-curricular aspects of the program.
Current members of the advisory board include:
Arie Belldegrun, M.D. (PAR'05, PAR'08, PAR'11)
Professor of Urology
Chief, Division of Urologic Oncology
Director, Institute of Urologic Oncology
Roy and Carol Doumani Chair in Urologic Oncology
UCLA School of Medicine
Rebecka Belldegrun, M.D. (PAR'05, PAR'08, PAR'11)
President and CEO
Bellco Capital, LLC
Ron Belldegrun (C'08)
Founder and CEO
Consumer Health Ventures
Robert Benz, M.D. (C'74, PAR'05, PAR'06)
Vice President of Medical Affairs
Lankenau Medical Center
Chief of Nephrology
Main Line Health Hospital
Laura Bessen, M.D.
Vice President, Head of U.S. Medical (retired)
David Blumberg (WG'90): Advisory Board Chair
Retired Principal and Advisory Sector Leader - Pharmaceuticals
VP Global Commercial Compliance - Teva Pharmaceuticals
Ellen Davis (W'85, PAR'13)
Member, Board of Overseers
Weill Cornell Medicine
Member, Board of Overseers
Melanoma Research Alliance
Benjamin Doranz, Ph.D. (GR'98, WG'01)
President and Chief Scientific Officer
Garret FitzGerald, M.D.
Professor of Medicine and Chair, Department of Pharmacology
University of Pennsylvania
M. Therese Flaherty, Ph.D.
Wharton Small Business Development Center
Sarah Fuller (CW'71, PAR'04, PAR'07)
Decision Resources, Inc.
Millennium Prevention Inc.
David Gluckman, M.D. (WG'98)
Vice Chairman of Investment Banking
Global Co-Head of Healthcare
Henry Gosebruch (W'95)
Chief Strategy Officer
Keith Gottesdiener, M.D. (MED'82)
Lorence Kim, M.D. (MED'99, WG'99)
Adam Koppel, M.D. Ph.D. (MED'95, GR'97, WG'00)
Senior Vice President, Chief Strategy Officer
Joan Lau, Ph.D. (ENG'92, GR'02, WG'08)
Militia Hill Ventures
Chief Operating Officer
Mathai Mammen, M.D., Ph.D.
Senior Vice President
Steven Nichtberger, M.D. (C'83, W'83)
Chairman & CEO
ControlRad Systems, Inc.
Paul Offit, M.D.
Chief of Infectious Diseases
Children’s Hospital of Philadelphia
Dinesh Patel, Ph.D. (PAR'08)
Signal Peak Ventures
Phil Ross, M.D.
Managing Director, Healthcare Investment Banking
Lee Schalop, M.D. (C'85, W'85)
Biotech Industry Angel Investor and Entrepreneur
Chief Business Officer
Barbara Schilberg, J.D.
Managing Director & Chief Executive Officer
Sheri Schully, Ph.D.
Senior Advisor for Disease Prevention
National Institutes of Health
Martin Silverstein, M.D. (C'76, PAR'11)
Gilead Sciences, Inc.
Richard L. Solit, M.D.
Adage Capital Management
Kuo Tong (C'89)
President and Founder
P. Roy Vagelos, M.D. (C'50) - honorary member
Chairman of the Board
Regeneron Pharmaceuticals, Inc.
Retired Chair of the Board and Chief Executive Officer